Program News
News and stories about members of the UNC Lineberger Immunology Research Program
-
Thomas C. Shea Clinical Cancer Symposium brings together national leaders in blood cancers
The inaugural symposium featured talks on adoptive cellular therapy for lymphoid malignancies and novel approaches for the treatment of acute myeloid leukemia, myelodysplastic syndromes and myeloproliferative neoplasms.
-
Rooted: Ilona Jaspers
UNC Lineberger member Ilona Jaspers, MS, PhD, has been contributing to research at Carolina for 26 years.
-
Gut microbiome can increase risk, severity of HIV, EBV disease
UNC researchers report that the gut microbiome has a significant impact on the acquisition of Epstein-Barr virus and human immunodeficiency virus-1 infection and plays a role in the course of disease.
-
American Association for Cancer Research’s annual meeting to feature UNC Lineberger experts, research
UNC Lineberger faculty and trainees will be presenting their research findings and sharing their insights at education sessions during the American Association for Cancer Research’s annual meeting April 14-19.
-
NCI awards Earp, Pylayeva-Gupta five-year, $2.69 million pancreatic cancer research grant
The NCI has awarded has awarded Shelley Earp, MD, and Yuliya Pylayeva-Gupta, PhD, a research project grant to investigate approaches to overcome barriers to pancreatic cancer immunotherapies.
-
Why don’t T cells destroy solid tumors during immunotherapy?
Jessica Thaxton, PhD, MsCR, and colleagues found that targeting key proteins that control the T cell response to stress could help researchers develop more potent cancer immunotherapies.
-
UNC Lineberger and UNC researchers discuss latest research at American Society of Hematology Annual Meeting
UNC Lineberger researchers will present the latest findings from studies and lead educational sessions at the 64th American Society of Hematology Annual Meeting in New Orleans, Dec. 10-13.
-
UNC Lineberger faculty recognized as world’s most highly cited researchers
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
-
Pylayeva-Gupta awarded Hettleman Prize
UNC named UNC Lineberger’s Yuliya Pylayeva-Gupta, PhD, one of four recipients of the Phillip and Ruth Hettleman Prize for Artistic and Scholarly Achievement.
-
Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies
UNC Lineberger researchers have found a possible way to overcome barriers that block anti-cancer immune responses. Their findings could have implications for treating solid tumors, including breast and pancreatic cancer.
-
UNC Lineberger creates RNA Discovery Center
The UNC RNA Discovery Center, led by Chad Pecot, MD, will cultivate an inclusive community of scientists dedicated to investigating all aspects of RNA biology.
-
Parents, supporters create new fund for CAR-T therapy
Inspired by the potential of immunotherapy in solid tumor cancers, Tom and Nancy Chewning established a fund to support Jonathan Serody, MD, and accelerate his work with CAR-T immunotherapy.
-
Baric, Ting elected to American Academy of Arts & Sciences
UNC Lineberger’s Ralph Baric, PhD, and Jenny P. Ting, PhD, have been elected to the American Academy of Arts and Sciences. They join seven other UNC Lineberger members with this honor.
-
Implant churns out CAR-T cells to combat cancer in animal models
Yevgeny Brudno, PhD, and colleagues from NC State University and UNC-Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T for attacking cancerous tumors.
-
Mark Foundation awards Pylayeva-Gupta three-year, $750,000 research grant
Yuliya Pylayeva-Gupta, PhD, is a recipient of The Mark Foundation for Cancer Research Emerging Leader Award. The funding will support her research focused on reprogramming B cell fate and function in cancer.